Thermo Fisher Scientific Palivizumab Monoclonal Antibody (2F12)

Thermo Fisher Scientific Palivizumab Monoclonal Antibody (2F12)

Applications and Tested Dilution

• ELISA (ELISA): 0.005–0.5 µg/mL

Product Specifications

Product Specific Information

• Reconstitute the lyophilized powder with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
• Lyophilized product remains stable up to 1 year at -20°C from date of receipt.
• Upon reconstitution, store for 2–3 weeks at 2–8°C or up to 12 months at -20°C or below.
• Avoid repeated freezing and thawing cycles.

Target Information

Palivizumab (trade name Synagis) is an FDA-approved drug for preventing respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa monoclonal antibody that binds the RSV envelope fusion protein (RSV F), blocking a critical step in the membrane fusion process.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.